arrow
Return

a b

delete2023-02-01
delete6
delete
OA
AI
M
Meiyu Zheng
L
Lu Wang
Y
Yuqing Sun
X
Xionge Pi
张
张文娟 (Wenjuan Zhang)
P
Pu Gao
S
Shengmin Lu *
W
Wei Liu *
DOI:10.1016/j.biopha.2022.114130delete
deleteOriginal
deleteShare
deleteSave
View PDF
Abstract

Abstract

En 中文
Phellinus baumii extract (PBE) possesses considerable alpha-glucosidase-inhibited activity. This study investigated the hypoglycemic effect in vitro and in vivo using a glucose consumption assay in HepG2 cells, intragastric admin-istration for ten weeks in STZ-induced mice, and intestinal flora fermentation in patients with type 2 diabetes to reveal the possible underlying mechanisms. PBE was prepared, including alpha-glucosidase-inhibited ethanol extract (EE) and aqueous extract (AE). In vitro, PBE promoted glucose consumption and enhanced glycogen content and hexokinase activity but lowered phosphoenolpyruvate carboxylase kinase activity in HepG2 cells. In vivo, PBE treatment significantly reduced the body weight (p < 0.05) and fasting blood glucose levels of diabetic mice (p < 0.01), with the lowest blood glucose level observed in the EE+AE group. Furthermore, the serum insulin levels and insulin resistance index (HOMA) of PBE-treated groups decreased significantly (p < 0.01). Moreover, gene expression levels of the IRS-1/PI3K/AKT pathway were significantly upregulated by PBE treatment (p < 0.01). In vitro fermentation demonstrated that EE significantly inhibited the production of H2S and NH3 in the intestinal flora fermentation model in diabetic patients (p < 0.05). In addition, the ratio of Firmicutes to Bacteroidetes was reduced, the growth of Lactobacillus and Prevotella 9 was promoted, and Pseudomonas aeruginosa was inhibited. This study provides new insights and clues for using PBE as a functional food and clinical drug for glycemic control.
Keywords:
Phellinus baumii
STZ-induced
Hypoglycemic effect
In vitro fermentation
Intestinal flora
AI Summary

AI Summary

Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.

Journal

B
Biomedicine and Pharmacotherapy
IF:
7.5
Papers:
1.6W
Citations:
8.2W

Organization

Z
Zhejiang Academy of Agricultural Sciences
Scholars:
5.1K
Papers: 3.3K
Citations: 6.4K
Cited Papers

Cited Papers

Aberrant intestinal microbiota in individuals with prediabetes
err2018-01-29
err344
errOAAI
errAllin, Kristine H.; Tremaroli, Valentina; Caesar, Robert; Jensen, Benjamin A. H.; Damgaard, Mads T. F.; Bahl, Martin I.; Licht, Tine R.; Hansen, Tue H.; Nielsen, Trine; Dantoft, Thomas M.; Linneberg, Allan; Jorgensen, Torben; Vestergaard, Henrik; Kristiansen, Karsten; Franks, Paul W.; Hansen, Torben; Backhed, Fredrik; Pedersen, Oluf
errShare
errSave
Evaluation of antioxidant and immune activity of Phellinus ribis glucan in mice
err2009-07-15
err58
PREAI
errYuan, Chengfu; Huang, Xiuning; Cheng, Li; Bu, Youquan; Liu, Geli; Yi, Faping; Yang, Zhengmei; Song, Fangzhou
errShare
errSave
Evidence for an increased sensitivity to Ca2+ in the flagella of sperm from tw32/+ mice
err2005-02-04
err0
PREAI
errCharles B. Lindemann; Jason S. Goltz; Kathleen S. Kanous; Tressa K. Gardner; Patricia Olds‐Clarke
errShare
errSave
Effect of chitooligosaccharides on human gut microbiota and antiglycation
err2020-08-01
err57
PREAI
errLiu, Wei; Li, Xiaoqiong; Zhao, Zhonglin; Pi, Xionge; Meng, Yanyu; Fei, Dibo; Liu, Daqun; Wang, Xin
errShare
errSave
researcher View more